Premium
Patterns of atypical antipsychotic therapy use in adults with bipolar I disorder in the USA
Author(s) -
Chen Wenjia,
DeVeaughGeiss Angela M.,
Palmer Liisa,
Princic Nicole,
Chen YaTing
Publication year - 2013
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.2326
Subject(s) - discontinuation , bipolar disorder , antipsychotic , concomitant , medicine , bipolar i disorder , persistence (discontinuity) , psychiatry , pediatrics , schizophrenia (object oriented programming) , mood , mania , geotechnical engineering , engineering
Objectives This study aims to describe the utilization patterns of atypical antipsychotics (AA) among insured patients with bipolar I disorder in the USA. Methods We studied patients with bipolar I disorder who newly initiated an oral AA between 2002 and 2008. Utilization measures included adherence [medication possession ratio (MPR) ≥80%], persistence (gaps ≤15 days between refills and an absence of ≥30 days of continuous concomitant non‐index AA use), non‐compliance (16–29 day gaps with no evidence of switch/augmentation), and discontinuation of the index AA (≥30 days without index AA, no evidence of switch/augmentation). Results The study included 16 807 patients: mean age 43.3 years, 67.7% female. Overall, adherence to the index AA was low (8.3%; mean MPR = 0.2). Only 10.5% of the patients were persistent to index AA, another 13.6% were non‐compliant, and 63.4% discontinued index AA with an average time to discontinuation of 66 days. A majority (69.5%) of the discontinued patients did not resume any antipsychotic therapy. Results were similar across insurance types and index AA. Conclusion Adherence to and persistence with AA treatment were low in new users with bipolar I disorder. Most patients discontinued the index AA and did not restart any antipsychotic treatment. Future study should distinguish physician‐directed discontinuation versus patient non‐adherence. Copyright © 2013 John Wiley & Sons, Ltd.